FNA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
FNA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Paragon 28's Net Cash per Share for the quarter that ended in Dec. 2024 was $-1.50.
The historical rank and industry rank for Paragon 28's Net Cash per Share or its related term are showing as below:
During the past 6 years, the highest Price-to-Net-Cash Ratio of Paragon 28 was 20.10. The lowest was 20.10. And the median was 20.10.
The historical data trend for Paragon 28's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paragon 28 Annual Data | |||||||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||
Net Cash per Share | Get a 7-Day Free Trial | -0.13 | 0.88 | -0.96 | -1.05 | -1.50 |
Paragon 28 Quarterly Data | |||||||||||||||||||
Dec19 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Net Cash per Share | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-1.05 | -1.35 | -1.40 | -1.48 | -1.50 |
For the Medical Devices subindustry, Paragon 28's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Paragon 28's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where Paragon 28's Price-to-Net-Cash falls into.
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
Paragon 28's Net Cash per Share for the fiscal year that ended in Dec. 2024 is calculated as
Net Cash per Share (A: Dec. 2024 ) | |||||||
= | (Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | - | Minority Interest) | / | Shares Outstanding (EOP) |
= | (34.58 | - | 160.131 | - | 0) | / | 83.857 |
= | -1.50 |
Paragon 28's Net Cash per Share for the quarter that ended in Dec. 2024 is calculated as
Net Cash per Share (Q: Dec. 2024 ) | = | (Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | - | Minority Interest) | / | Shares Outstanding (EOP) |
= | (34.58 | - | 160.131 | - | 0) | / | 83.857 |
= | -1.50 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paragon 28 (NYSE:FNA) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
Thank you for viewing the detailed overview of Paragon 28's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Mvm Partners, Llc | 10 percent owner | OLD CITY HALL, 45 SCHOOL STREET, BOSTON MA 02108 |
Kristina Wright | director | C/O PARAGON 28, INC., 14445 GRASSLANDS DRIVE, ENGLEWOOD CO 80112 |
Albert Dacosta | director, officer: See Remarks | C/O PARAGON 28, INC., 14445 GRASSLANDS DRIVE, ENGLEWOOD CO 80112 |
Robert S Mccormack | officer: See Remarks | C/O VIEWRAY, INC., 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH 44146 |
Thomas P Schnettler | director | 800 NICOLLET MALL, J1012057, MINNEAPOLIS MN 55402-7020 |
B. Ag Bird | 10 percent owner | BAHNHOFSTRASSE 7, ZUG V8 CH-6300 |
Matthew Jarboe | officer: Chief Commercial Officer | C/O PARAGON 28, INC., 14445 GRASSLANDS DRIVE, ENGLEWOOD CO 80112 |
Partners Llp Mvm | 10 percent owner | 30 ST. GEORGE STREET, LONDON X0 W1S SFH |
Jonathan I Friedman | officer: General Counsel | DENTSPLY SIRONA INC., 30-30 47TH AVENUE, SUITE 500, LONG ISLAND CITY NY 11101 |
Lee Rosenthal | 10 percent owner | C/O PARAGON 28, INC., 14445 GRASSLANDS DRIVE, ENGLEWOOD CO 80112 |
Quentin S. Blackford | director | 7475 LUSK BLVD., SAN DIEGO CA 92121 |
Frank S. Bono | officer: Chief Technology Officer | 5677 AIRLINE ROAD, ARLINGTON TN 38002 |
Jason Allan Edie | officer: Chief Technology Officer | C/O PARAGON 28, INC., 14445 GRASSLANDS DRIVE, ENGLEWOOD CO 80112 |
Erik E Mickelson | officer: Chief Accounting Officer | C/O PARAGON 28, INC., 14445 GRASSLANDS DRIVE, ENGLEWOOD CO 80112 |
Meghan Scanlon | director | C/O BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752 |
From GuruFocus
By PRNewswire • 01-31-2025
By GuruFocus News • 03-21-2025
By GuruFocus News • 03-03-2025
By Business Wire • 03-24-2025
By GuruFocus News • 01-29-2025
By GuruFocus News • 01-28-2025
By Marketwired • 02-14-2025
By Business Wire • 01-30-2025
By GuruFocus News • 01-30-2025
By GuruFocus News • 03-01-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.